A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD

RATIONALE: Vortioxetine has reduced depressive symptoms in adults with major depressive disorder (MDD) in multiple clinical trials. OBJECTIVES: The aim of this study is to evaluate the efficacy, safety, and tolerability of vortioxetine 15 and 20 mg vs placebo in adults with MDD. METHODS: Patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahableshwarkar, Atul R., Jacobsen, Paula L., Chen, Yinzhong, Serenko, Michael, Trivedi, Madhukar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432084/
https://www.ncbi.nlm.nih.gov/pubmed/25575488
http://dx.doi.org/10.1007/s00213-014-3839-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432084/
https://www.ncbi.nlm.nih.gov/pubmed/25575488
http://dx.doi.org/10.1007/s00213-014-3839-0

Ejemplares similares